Skip to main content
. 2021 Mar 15;12(3):280. doi: 10.1038/s41419-021-03562-6

Fig. 4. Effect of PDX in alleviating inflammation and joint destruction in Nlrp3−/− CIA mice.

Fig. 4

A Timeline of PDX treatment experiment in Nlrp3+/+ and Nlrp3−/− mouse CIA models. B Clinical scores of PDX-treated CIA models established using Nlrp3+/+ and Nlrp3−/− CIA mice. Statistical significance was defined by ANOVA of repeated measurements. C H&E staining of knee joints from PDX-treated Nlrp3+/+ and Nlrp3−/− CIA mice (40×, 100×) (upper panel) and histopathological analysis of H&E staining (F[3,40] = 54.02) (lower panel). D Concentrations of serum cytokines IL-1β, IL-18, IL-17A, IL-10, and TGF-β in PDX-treated Nlrp3+/+ and Nlrp3−/− CIA mice as shown by ELISA. E Expression of NLRP3 mRNA in lymphocytes from PDX-treated Nlrp3+/+ and Nlrp3−/− CIA mice as shown by RT-qPCR (F[6,18] = 18.62). F NLRP3 protein levels in lymph nodes of PDX-treated Nlrp3+/+ and Nlrp3−/− CIA mice as shown by WB.